The last observation is consistent with a difference in the mechanisms underlying the anti-tumor action of ATRA in MB-157 and HCC-1599 cells, indicating that MYC-targeting is not a major determinant of the MB-157 growth-inhibitory response to the retinoid. The gene discussed is MYC; the disease is hepatocellular carcinoma.